Enzon Pharmaceuticals, Inc.
ENZN
$0.04
-$0.01-13.33%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.41M | -1.33M | -66.00K | 778.00K | 1.52M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 280.00K | 314.00K | 360.00K | 342.00K | -195.00K |
| Change in Net Operating Assets | 28.00K | 358.00K | -41.00K | 2.00K | 24.00K |
| Cash from Operations | -2.10M | -660.00K | 253.00K | 1.12M | 1.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.28M | -1.28M | -1.28M | -1.28M | -1.28M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.28M | -1.28M | -1.28M | -1.28M | -1.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.38M | -1.94M | -1.02M | -153.00K | 76.00K |